News Article

EU ophthalmology attracts investors

12 June 2024

In the latest edition of LaingBuisson HealthcareMarkets, Candesic Senior Partner Marc Kitten investigates why, and looks at its growth potential and recent advances in technology which could transform the market.

With heavy hitters in the independent market like Veonet, Sanoptis, ARTEMIS Augenklinik, Clinica Bavaria, and Optegra Eye Health Care, the race is on to become the first truly pan-European group.

And while historically the UK and Germany have attracted a lot of interest because of outsourcing and/or rollup opportunities, there are eye-catching opportunities elsewhere, including Eastern Europe.

To find out more about these opportunities and advances in ophthalmic technology, click to read the full article below.

To read more on this subject from Candesic, click here for our interview with Tim Clover from ophthalmic medical device specialists Rayner: and here for our interview with Tony Veverka, CEO of Y1 Capital which has just moved into ophthalmology with Transform Healthcare:

Candesic Senior Partner Marc Kitten has extensive experience advising on health and social care, pharma, life sciences, and medtech across Europe. To find out more or simply start a conversation, email [email protected]. We would love to hear from you.